checkAd

    EQS-News  117  0 Kommentare Formycon reports on the results of the Annual General Meeting

    Für Sie zusammengefasst
    • Formycon AG reports on Annual General Meeting results
    • Shareholders approve all agenda items and acts of Management Board
    • Supervisory Board expands to five members, new Chairman elected

    EQS-News: Formycon AG / Key word(s): AGM/EGM/Miscellaneous
    Formycon reports on the results of the Annual General Meeting

    13.06.2024 / 15:30 CET/CEST
    The issuer is solely responsible for the content of this announcement.


    Press Release // June 13, 2024

    Formycon reports on the results of the Annual General Meeting

    • Management provides detailed report on financial year 2023 and current company performance
    • Shareholders approve all agenda items and formally approve the acts of the members of the Management Board and Supervisory Board by large majority
    • Supervisory Board becomes more international and expands to five members; Colin Bond, Dr Bodo Coldewey and Nicholas Haggar elected as new members of the Supervisory Board
    • Supervisory Board elects Wolfgang Essler as new Chairman

    Planegg-Martinsried, Germany – Formycon AG (FSE: FYB, “Formycon”) held its Annual General Meeting on 12 June 2024 as an in-person event in Munich. In its presentation, the Management Board provided shareholders with a detailed report on the company's development and answered all questions in the general debate. Dr Olaf Stiller, long-standing Chairman of the Supervisory Board, chaired the Annual General Meeting for the last time and was bid farewell with great appreciation for his successful collaboration.

    The represented shareholders followed the proposals of the Management Board and Supervisory Board and approved all of the Executive Board’s proposed resolution resolutions with large majorities. Both the members of the Management Board and the Supervisory Board were given a formal approval of their actions with majorities of over 96 per cent in each case.

    In order to reflect a more international focus and expanded industry and financial expertise on the Supervisory Board in future, new and independent members were elected to the Supervisory Board along with the decision to increase the size of the Supervisory Board from four to five members. Dr Bodo Coldewey, Managing Director of WEGA Invest GmbH, the Wendeln family office, and Nicholas Haggar, currently CEO of healthqube Ltd. and a long-standing executive at major pharmaceutical companies, were elected as new members of the Supervisory Board by large majorities. Dr Olaf Stiller and his deputy Peter Wendeln resigned from the Supervisory Board as planned with effect from the end of the Annual General Meeting. Colin Bond, currently still CFO of Sandoz Group AG, was also elected to the expanded Supervisory Board by a large majority with effect from 1 October 2024. The Supervisory Board was constituted immediately after the Annual General Meeting and elected Wolfgang Essler as the new Chairman and Nicholas Haggar as Deputy Chairman.

    Seite 1 von 4
    N.C. State University: Jeff Bezos spendet 30 Millionen Dollar an Lab-Grown-Meat-Unternehmen



    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-News Formycon reports on the results of the Annual General Meeting EQS-News: Formycon AG / Key word(s): AGM/EGM/Miscellaneous Formycon reports on the results of the Annual General Meeting 13.06.2024 / 15:30 CET/CEST The issuer is solely responsible for the content of this announcement. Press Release // June 13, …

    Schreibe Deinen Kommentar

    Disclaimer